Seeing Is Believing
DSGN is currently covered by 2 analysts with an average price target of $17.24. This is a potential upside of $4.75 (38.03%) from yesterday's end of day stock price of $12.49.
Design Therapeutics's activity chart (see below) currently has 25 price targets and 29 ratings on display. The stock rating distribution of DSGN is 80% HOLD and 20% BUY.
Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 82.33 days.
Highest price target for DSGN is $14, Lowest price target is $14, average price target is $14.
Most recent stock forecast was given by JOSEPH SCHWARTZ from LEERINK on 03-Dec-2025. First documented stock forecast 20-Apr-2021.
Currently out of the existing stock ratings of DSGN, 4 are a HOLD (80%), 1 are a BUY (20%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 03-Dec-2025
$14
$2.77 (24.67%)
4 months 7 days ago
(03-Dec-2025)
0/3 (0%)
$4.23 (43.30%)
Hold Since 07-May-2024
$12
$0.77 (6.86%)
$42
1 years 11 months 3 days ago
(07-May-2024)
0/4 (0%)
$7.31 (155.86%)
Hold Since 14-Nov-2023
$5
$-6.23 (-55.48%)
$6
2 years 4 months 27 days ago
(14-Nov-2023)
3/6 (50%)
$2.71 (118.34%)
247
What is DSGN (Design Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on DSGN (Design Therapeutics) with a proven track record?
Which analyst has the current lower performing score on DSGN (Design Therapeutics) with a proven track record?
Which analyst has the most public recommendations on DSGN (Design Therapeutics)?
Which analyst is the currently most bullish on DSGN (Design Therapeutics)?
Which analyst is the currently most reserved on DSGN (Design Therapeutics)?